Supernus Pharmaceuticals, Inc. (LON:0LB2)
London · Delayed Price · Currency is GBP · Price in USD 54.95
+2.16 (4.09%)
At close: Oct 29, 2025
Supernus Pharmaceuticals Market Cap
Supernus Pharmaceuticals has a market cap or net worth of 2.36 billion as of October 30, 2025. Its market cap has increased by 69.60% in one year.
Market Cap
2.36B
Enterprise Value
1.99B
Revenue
485.47M
Ranking
n/a
PE Ratio
50.10
Stock Price
54.95
Market Cap Chart
Since May 1, 2012, Supernus Pharmaceuticals's market cap has increased from 79.17M to 2.36B, an increase of 2,878.93%. That is a compound annual growth rate of 28.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 2.24B | 40.73% |
| Dec 31, 2024 | 1.59B | 28.49% |
| Dec 29, 2023 | 1.24B | -22.44% |
| Dec 30, 2022 | 1.60B | 39.74% |
| Dec 31, 2021 | 1.15B | 17.96% |
| Dec 31, 2020 | 970.89M | 3.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.77B |
| GSK plc | 70.40B |
| Haleon | 30.72B |
| Smith & Nephew | 11.60B |
| ConvaTec Group | 4.82B |
| Hikma Pharmaceuticals | 4.04B |
| HUTCHMED (China) | 1.88B |
| Genus | 1.68B |